Highlights Eli Lilly and Company Deutsche Boerse AG

Equities

LLY

US5324571083

Real-time Estimate Tradegate Other stock markets 07:59:40 2024-06-20 EDT			5-day change	1st Jan Change
832.9 ^EUR	+0.06%		+1.77%	+58.23%

12:30pm	Lilly files additional lawsuits over US sales of counterfeit Mounjaro	RE
12:00pm	Food companies with Ozempic-friendly snacks and meals wade carefully into weight-loss waters	RE

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Lilly files additional lawsuits over US sales of counterfeit Mounjaro	06:30am	RE
Food companies with Ozempic-friendly snacks and meals wade carefully into weight-loss waters	06:00am	RE
Health Care Flat as Traders Wait More Obesity-Drug Updates - Health Care Roundup	06-17	DJ
Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup	06-14	DJ
Musk wins pay approval but still faces Tesla's floundering stock and rich valuation	06-14	RE
Employer coverage for weight-loss drugs rises sharply, survey finds	06-13	RE
Eli Lilly Gets FDA Approval for Selpercatinib to Treat Thyroid Cancer	06-12	MT
Biogen executive plays down looming competition for its Alzheimer's drug	06-12	RE
Social Buzz: Wallstreetbets Stocks Mixed Premarket Wednesday; Oracle to Advance, AST SpaceMobile to Open Lower	06-12	MT
Sector Update: Health Care Stocks Softer Late Afternoon	06-11	MT
Sector Update: Health Care Stocks Decline Tuesday Afternoon	06-11	MT
Swiss Market Index Falls as US Rate Jitters Persist	06-11	MT
Global markets live: GSK, Tesla, Intel, General Motors, Gamestop...	06-11
Dpa-AFX Overview: COMPANIES as of 11/06/2024 - 15:15	06-11	DP
Futures fall as markets await Fed decision, CPI data	06-11	RE
Japan's Nikkei gains on chip shares boost; Fed policy in focus	06-11	RE
Eli Lilly Exec Says Trial Results for Experimental Obesity Pill Expected in April 2025	06-11	MT
Eli Lilly exec expects obesity pill data in April 2025	06-10	RE
FDA advisory panel votes in favor of data for Lilly Alzheimer's drug	06-10	RE
US FDA advisers to review Eli Lilly Alzheimer's drug	06-10	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm